Aurobindo to acquire Lannett Company for Rs. 2,185 Cr
The transaction aligns with Aurobindo’s strategic objective to expand its U.S. manufacturing footprint by enhancing its existing domestic capabilities
The transaction aligns with Aurobindo’s strategic objective to expand its U.S. manufacturing footprint by enhancing its existing domestic capabilities
The company received one observation in the Form-483
Revenue increased 11.4 per cent to Rs. 8,545 crore
The companies admitted taking part in the cartel in exchange for reduced fines but Alchem did not settle
The acquisition of Pivya is an important step in Alembic’s ability to provide branded pharmaceutical product to the US Healthcare market
Loteprednol Etabonate Ophthalmic Gel, 0.38% is a corticosteroid indicated for the treatment of postoperative inflammation and pain following ocular surgery
Review will evaluate effectiveness in treating alcohol withdrawal syndrome and supporting abstinence, as well as measures to mitigate risk of abuse
Dilip Shanghvi to continue as the Executive Chairman of the Board
The NPPA has capped prices for 41 drug combinations including diabetes, cholesterol, and sleep disorder treatments
The approval is for the generic version of Victoza, indicated for the treatment of insufficiently controlled Type 2 Diabetes Mellitus
Subscribe To Our Newsletter & Stay Updated